tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CYTO

Altamira Therapeutics Transitions to OTCQB Following Nasdaq Delisting
Company AnnouncementsAltamira Therapeutics Transitions to OTCQB Following Nasdaq Delisting
4M ago
6K
CYTO
Altamira Therapeutics announces transition from Nasdaq to OTC markets
PremiumThe Fly
Altamira Therapeutics announces transition from Nasdaq to OTC markets
4M ago
CYTO
Altamira Therapeutics provides update on Nasdaq listing
PremiumThe Fly
Altamira Therapeutics provides update on Nasdaq listing
6M ago
CYTO
Altamira Therapeutics Faces Nasdaq Delisting
PremiumCompany Announcements
Altamira Therapeutics Faces Nasdaq Delisting
6M ago
6K
CYTO
Altamira obtains extended ISO 13485 quality management system certification
PremiumThe Fly
Altamira obtains extended ISO 13485 quality management system certification
6M ago
CYTO
Altamira Therapeutics Reports Narrowed Losses
PremiumCompany AnnouncementsAltamira Therapeutics Reports Narrowed Losses
7M ago
6K
CYTO
Altamira Therapeutics reports 1H EPS ($2.11) vs. ($21.55) last year
Premium
The Fly
Altamira Therapeutics reports 1H EPS ($2.11) vs. ($21.55) last year
7M ago
CYTO
Altamira Therapeutics sees FY24 total cash needs $5.8M-$7M
Premium
The Fly
Altamira Therapeutics sees FY24 total cash needs $5.8M-$7M
7M ago
CYTO
Altamira Issues Pre-Funded Share Purchase Warrant
PremiumCompany Announcements
Altamira Issues Pre-Funded Share Purchase Warrant
7M ago
6K
CYTO
Altamira Therapeutics announces pricing of $12M offering
PremiumThe Fly
Altamira Therapeutics announces pricing of $12M offering
7M ago
CYTO
Altamira announces expansion of Bentrio license, distribution agreement
PremiumThe Fly
Altamira announces expansion of Bentrio license, distribution agreement
7M ago
CYTO
Altamira Therapeutics announces extension of Bentrio distribution agreement
PremiumThe Fly
Altamira Therapeutics announces extension of Bentrio distribution agreement
8M ago
CYTO
Altamira Therapeutics files to sell common stock, warrants, no amount given
PremiumThe FlyAltamira Therapeutics files to sell common stock, warrants, no amount given
8M ago
CYTO
Altamira Therapeutics announces confirmed suitability of Bentrio for athletes
Premium
The Fly
Altamira Therapeutics announces confirmed suitability of Bentrio for athletes
8M ago
CYTO
Altamira Therapeutics announces publication of article on Zbtb46 mRNA
Premium
The Fly
Altamira Therapeutics announces publication of article on Zbtb46 mRNA
8M ago
CYTO
Altamira Therapeutics announces publication of preclinical data on SOD2 mRNA
PremiumThe Fly
Altamira Therapeutics announces publication of preclinical data on SOD2 mRNA
9M ago
CYTO
Altamira Therapeutics announces publication on betahistine
PremiumThe Fly
Altamira Therapeutics announces publication on betahistine
10M ago
CYTO
Altamira Therapeutics announces publication of results from NASAR trial
PremiumThe Fly
Altamira Therapeutics announces publication of results from NASAR trial
11M ago
CYTO
Altamira Shareholders Approve Key Corporate Changes
PremiumCompany Announcements
Altamira Shareholders Approve Key Corporate Changes
11M ago
6K
CYTO
Altamira Therapeutics files provisional patent application for OligoPhore
PremiumThe FlyAltamira Therapeutics files provisional patent application for OligoPhore
11M ago
CYTO
Altamira Therapeutics announces publication of results from Bentrio trial
Premium
The Fly
Altamira Therapeutics announces publication of results from Bentrio trial
12M ago
CYTO
Altamira Therapeutics Announces 2024 Annual Meeting
Premium
Company Announcements
Altamira Therapeutics Announces 2024 Annual Meeting
12M ago
6K
CYTO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >